Thu, Nov 21, 2024
[Archive]
Volume 11, Issue 1 (Winter-In Press 2025)
JCCNC 2025, 11(1): 0-0 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Mardani M, Besharat M A, Firoozi M, Vosoughi T. Investigating the Effectiveness of Paradox Therapy on Death Anxiety in Female Patients with Cancer. JCCNC 2025; 11 (1)
URL: http://jccnc.iums.ac.ir/article-1-637-en.html
URL: http://jccnc.iums.ac.ir/article-1-637-en.html
1- Department of Psychology, Faculty of Psychology and Educational Sciences, University of Tehran, Tehran, Iran.
2- Department of Psychology, Faculty of Psychology and Educational Science, University of Tehran, Tehran, Iran. ,mfiroozy@ut.ac.ir
3- Internal Medicine Department, Hematologist and Medical Oncologist, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
2- Department of Psychology, Faculty of Psychology and Educational Science, University of Tehran, Tehran, Iran. ,
3- Internal Medicine Department, Hematologist and Medical Oncologist, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Abstract: (84 Views)
Background: After cancer diagnosis, death anxiety continuously challenges the patient's life. Individuals diagnosed with cancer are forced to think of and confront the end of their lives. The present research was conducted to determine the effect of paradox therapy (PTC) on death anxiety of female patients with cancer.
Methods: This research was a quasi- experimental study with a pretest- posttest control group design. The statistical population consisted of all female patients with cancer, referring to a specialized cancer treatment center in Ahvaz province, Iran, from January 21 to February 19, 2023 who were first recruited by convenience sampling based on inclusion criteria and then were randomly assigned into experimental (n=26) and control (n=26) groups. The data were collected using Death Anxiety Scale (DAS). The experimental group received 6 sessions of individual, face-to- face paradox therapy (PTC). The duration of each session was 45 minutes. The dependent variable was assessed at three distinct time points: initially at the pre-test phase, subsequently upon the conclusion of the psychotherapy intervention, and finally, one month following the termination of psychotherapy. Data analysis was done using descriptive statistics and to test the research hypothesis, mixed analysis of variance was used in SPSS-25 software. The significance level was set at P < 0.05.
Results: A significant effect of time on death anxiety scores was observed (F=169.77, P<0.0001). Post hoc analysis revealed significant differences in the mean death anxiety scores across the pretest, posttest, and follow-up assessments. Additionally, a significant interaction between time and treatment group was noted (F=153.58, P<0.0001). According to the Bonferroni test, the experimental group exhibited a significant reduction in death anxiety at posttest compared to pretest (P<0.0001), and this reduction persisted at follow-up stage (P<0.0001). Moreover, death anxiety continued to decrease from posttest to follow-up. These results supported the study hypothesis.
Conclusion: By elevating our understanding of the effect of PTC on death anxiety in cancer patients, the current research has tried to fill a major gap in psychosocial oncology. Perceiving the long-term effect of PTC can lay the groundwork for following care plans and long-term support for cancer patients.
Methods: This research was a quasi- experimental study with a pretest- posttest control group design. The statistical population consisted of all female patients with cancer, referring to a specialized cancer treatment center in Ahvaz province, Iran, from January 21 to February 19, 2023 who were first recruited by convenience sampling based on inclusion criteria and then were randomly assigned into experimental (n=26) and control (n=26) groups. The data were collected using Death Anxiety Scale (DAS). The experimental group received 6 sessions of individual, face-to- face paradox therapy (PTC). The duration of each session was 45 minutes. The dependent variable was assessed at three distinct time points: initially at the pre-test phase, subsequently upon the conclusion of the psychotherapy intervention, and finally, one month following the termination of psychotherapy. Data analysis was done using descriptive statistics and to test the research hypothesis, mixed analysis of variance was used in SPSS-25 software. The significance level was set at P < 0.05.
Results: A significant effect of time on death anxiety scores was observed (F=169.77, P<0.0001). Post hoc analysis revealed significant differences in the mean death anxiety scores across the pretest, posttest, and follow-up assessments. Additionally, a significant interaction between time and treatment group was noted (F=153.58, P<0.0001). According to the Bonferroni test, the experimental group exhibited a significant reduction in death anxiety at posttest compared to pretest (P<0.0001), and this reduction persisted at follow-up stage (P<0.0001). Moreover, death anxiety continued to decrease from posttest to follow-up. These results supported the study hypothesis.
Conclusion: By elevating our understanding of the effect of PTC on death anxiety in cancer patients, the current research has tried to fill a major gap in psychosocial oncology. Perceiving the long-term effect of PTC can lay the groundwork for following care plans and long-term support for cancer patients.
Type of Study: Research |
Subject:
General
Received: 2024/07/20 | Accepted: 2024/10/13 | Published: 2025/01/1
Received: 2024/07/20 | Accepted: 2024/10/13 | Published: 2025/01/1
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
Copyright © The Author(s);
This is an open access article distributed under the terms of the Creative Commons Attribution License (CC-By-NC), which permits use, distribution, and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
Contact Information
